Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06630325
What this trial is testing

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more
OHSU Knight Cancer Institute 6
Not applicableStudy completedNCT05510908
What this trial is testing

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Who this might be right for
HIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more
AIDS Malignancy Consortium 460
Very early researchActive Not RecruitingNCT04541108
What this trial is testing

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Who this might be right for
Solid Tumor
Presage Biosciences 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07650838
What this trial is testing

OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS)

Who this might be right for
Soft Tissue Sarcoma (STS)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Not applicableUnknownNCT04990076
What this trial is testing

Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology

Who this might be right for
Myoma;UterusSarcoma Uterus
Universitaire Ziekenhuizen KU Leuven 1,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07820033
What this trial is testing

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial

Who this might be right for
Advanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of Bone+3 more
University Health Network, Toronto 46
Not applicableEnded earlyNCT02900248
What this trial is testing

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

Who this might be right for
NeoplasmsLung NeoplasmsColon Neoplasms+22 more
CureOne 23
Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01118078
What this trial is testing

Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more
Children's Oncology Group 185
Testing effectiveness (Phase 2)UnknownNCT00204568
What this trial is testing

Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)

Who this might be right for
Sarcoma, Soft Tissue
University Hospital Schleswig-Holstein 117
Not applicableLooking for participantsNCT04749446
What this trial is testing

Study on Clinical Features and Outcomes of Breast Sarcoma

Who this might be right for
Breast Sarcoma
Italian Sarcoma Group 300
Testing effectiveness (Phase 2)UnknownNCT04589754
What this trial is testing

Adriamycin and Ifosfamide Combined With Sintilimab

Who this might be right for
Soft Tissue Sarcoma
Sun Yat-sen University 176
Testing effectiveness (Phase 2)Study completedNCT01764802
What this trial is testing

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerStage I Uterine Sarcoma+59 more
Ohio State University Comprehensive Cancer Center 100
Early research (Phase 1)WithdrawnNCT02557854
What this trial is testing

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

Who this might be right for
RhabdomyosarcomaNeuroblastomaSarcoma+3 more
Theodore Laetsch
Testing effectiveness (Phase 2)Ended earlyNCT05116683
What this trial is testing

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Who this might be right for
LeiomyosarcomaLiposarcoma
Benjamin Izar 4
Not applicableEnded earlyNCT02901405
What this trial is testing

Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery

Who this might be right for
SarcomaWound Infection
NHS Greater Glasgow and Clyde 17
Testing effectiveness (Phase 2)Study completedNCT01210222
What this trial is testing

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more
Gynecologic Oncology Group 35
Not applicableWithdrawnNCT01034566
What this trial is testing

Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal Sarcoma

Who this might be right for
Adult Soft Tissue Sarcoma
Abramson Cancer Center at Penn Medicine
Next Page